» Articles » PMID: 25153460

Cancer Screening Among Immigrants Living in Urban and Regional Australia: Results from the 45 and Up Study

Overview
Publisher MDPI
Date 2014 Aug 26
PMID 25153460
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Over 25% of the Australian population are immigrants, and are less active participants in cancer screening programmes. Most immigrants live in urban areas of Australia, but a significant proportion (~20%), live in regional areas. This study explored differences in cancer screening participation by place of birth and residence. Self-reported use of mammogram, faecal occult blood test (FOBT), and/or prostate specific antigen (PSA) tests was obtained from 48,642 immigrants and 141,275 Australian-born participants aged 50 years or older in the 45 and Up Study (New South Wales, Australia 2006-2010). Poisson regression was used to estimate relative risks of test use, adjusting for key socio-demographic characteristics. Overall, immigrants from Asia and Europe were less likely to have had any of the tests in the previous two years than Australian-born participants. Regional Australian-born participants were more likely to have had any of the tests than those living in urban areas. Regional immigrant participants were more likely to have had an FOBT or PSA test than those living in urban areas, but there were no differences in mammograms. This report identifies key immigrant groups in urban and regional areas that policymakers and healthcare providers should target with culturally appropriate information to promote cancer screening.

Citing Articles

Incidence profile of four major cancers among migrants in Australia, 2005-2014.

Yu X, Weber M, Smith D, Velentzis L, Kliewer E, David M J Cancer Res Clin Oncol. 2023; 149(11):8317-8325.

PMID: 37072554 PMC: 10374701. DOI: 10.1007/s00432-023-04764-5.


Breast cancer screening practices and associated factors among Chinese-Australian women living in Sydney: A cross-sectional survey study.

Wang L, Mackenzie L, Hossain Z Nurs Health Sci. 2022; 24(1):293-303.

PMID: 35106873 PMC: 9305288. DOI: 10.1111/nhs.12925.


Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia.

Feletto E, Lew J, Worthington J, He E, Caruana M, Butler K BMJ Open. 2020; 10(6):e036475.

PMID: 32565470 PMC: 7307542. DOI: 10.1136/bmjopen-2019-036475.


An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry.

Cole-Clark D, Nair-Shalliker V, Bang A, Rasiah K, Chalasani V, Smith D Sci Rep. 2018; 8(1):7167.

PMID: 29740153 PMC: 5940665. DOI: 10.1038/s41598-018-25408-6.


Variations in outcomes by residential location for women with breast cancer: a systematic review.

Dasgupta P, Baade P, Youlden D, Garvey G, Aitken J, Wallington I BMJ Open. 2018; 8(4):e019050.

PMID: 29706597 PMC: 5935167. DOI: 10.1136/bmjopen-2017-019050.


References
1.
Brown W, Consedine N, Magai C . Time spent in the United States and breast cancer screening behaviors among ethnically diverse immigrant women: evidence for acculturation?. J Immigr Minor Health. 2006; 8(4):347-58. DOI: 10.1007/s10903-006-9005-y. View

2.
Breslow N, Day N . Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987; (82):1-406. View

3.
Mealing N, Banks E, Jorm L, Steel D, Clements M, Rogers K . Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol. 2010; 10:26. PMC: 2868856. DOI: 10.1186/1471-2288-10-26. View

4.
Ranasinghe W, Kim S, Lawrentschuk N, Sengupta S, Hounsome L, Barber J . Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia. BJU Int. 2013; 113(1):77-83. DOI: 10.1111/bju.12354. View

5.
Watts G . UK Biobank gets 10% response rate as it starts recruiting volunteers. BMJ. 2007; 334(7595):659. PMC: 1839218. DOI: 10.1136/bmj.39167.407616.DB. View